Cargando…
Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring
While care models adapt to the COVID‐19 pandemic with virtual and hybrid visits, clinical factors associated with treatment changes among ambulatory pediatric pulmonary arterial hypertension (PAH) patients are not well characterized. To understand which data critically altered treatment recommendati...
Autores principales: | Critser, Paul J., Collins, Shane L., Elia, Eleni G., McSweeney, Julia, Leary, Brienne, Sleeper, Lynn A., Mullen, Mary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382461/ https://www.ncbi.nlm.nih.gov/pubmed/35991680 http://dx.doi.org/10.1002/pul2.12121 |
Ejemplares similares
-
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
por: McSweeney, Julia, et al.
Publicado: (2023) -
Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network
por: Jackson, Emma O., et al.
Publicado: (2021) -
Hemodynamic profiles of arterial hypertension with ambulatory blood pressure monitoring
por: Aristizábal-Ocampo, Dagnovar, et al.
Publicado: (2023) -
Ambulatory Blood Pressure Monitoring in Resistant Hypertension
por: Syrseloudis, Dimitrios, et al.
Publicado: (2011) -
Ambulatory blood pressure monitoring for the management of hypertension
por: Cheng, Yibang, et al.
Publicado: (2022)